INSIGHTS ON DRUG DISCOVERY

• Long-Acting GnRH Antagonist For Advanced Prostate Cancer

  Achieve rapid testosterone suppression for 6+ months with a novel low-volume subcutaneous depot formulation, eliminating the initial surge and offering a new approach for advanced prostate cancer treatment.

• Characterization And Functionality Of SEVs From Different MSC Purification Methods

  Comparing two purification approaches for mesenchymal stem cell-derived small extracellular vesicles shows where identity, purity, and in vitro bioactivity align and where they diverge.

• Overview Of Recombinant Protein Expression Systems

  Compare leading protein expression platforms and see how complexity, scalability, cost, and quality shape the path to commercial production.

• From Sequence To Scale In Seven Months

  Accelerate recombinant protein development from sequence to scale while maintaining stable expression, manufacturing efficiency, and critical quality attributes.

• Manufacturing Glycosylated Erythropoietin Without 𝛼1,3-Fucosylation

  9/26/2026

  See how expression hosts affect recombinant EPO glycosylation, bioactivity, and consistency, with reproducible N-glycan profiles and absence of α1,3-linked fucosylation.

• The Art Of Protein Expression: A Guide To Understanding Difficult-To-Express Proteins

  9/26/2026

  Protein expression failures often result from misfolding, PTMs, assembly issues, insolubility, and toxicity. Understanding their interplay can improve yields.

• Three Success Factors To Accelerate Your Program To Clinical Trial

  9/23/2026

  Accelerating clinical timelines starts with a strong foundation. Discover how smart development strategies can reduce risk, conserve resources, and support future scale-up.

• Unlocking Challenging Targets With Macrocycle DNA-Encoded Libraries

  9/22/2026

  Discover how macrocycle DNA-encoded libraries can uncover new opportunities for challenging targets and help researchers translate promising screening hits into starting points for drug discovery.

• AI Enabled Pharmaceutical Cocrystal Screening

  9/3/2026

  Cocrystal candidate screening is resource-intensive and prone to gaps. This paper examines how AI-based modeling, trained on more than 20,000 data points, can sharpen candidate prioritization without sacrificing scientific rigor.